Skip to main content

Superlab Suisse heading to Basel

| News

Superlab Suisse heading to Basel


Superlab Suisse is bringing its Lab-as-a-Service business concept to Basel. The company will open a new location with lab and research space in the beginning of 2024 at the city’s Stücki Park.

Superlab Suisse will offer laboratories in Basel (img: Superlab Suisse)

Superlab Suisse is establishing a presence in Basel. Founded in 2019, the Zurich-based firm will be offering its laboratory services from Stücki Park in Basel. Superlab Suisse will have one high rise building with lab and research space covering an area of 6,200 square meters at the Innovation Center for Life Sciences in Stuecki Park Basel North.

The Superlab Suisse business concept is directed towards biotechnology, pharmaceutical and medtech companies, and encompasses lab facilities, state-of-the-art equipment, professional and concierge services as well as financing support. “These companies should have to worry as little as possible about infrastructure, allowing them instead to focus their investments entirely on research and innovation”, comments CEO Zhang Xi.

Entire life sciences value chain available

Superlab Suisse already has laboratories based in Lausanne and in 2024 also in Schlieren in the canton of Zurich. The company now also has its sights set on tapping into one of the most important life sciences clusters in Europe and around the world. As the company explains, the entire life sciences value chain can be found in the Basel Area. This ranges from research and startups all the way through to manufacturing, commercialization and distribution activities. Therefore, there is a “large talent pool of experienced specialists, suppliers and service providers at every stage and for every function of your company”.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More